00546 FUFENG GROUP
- 5.140
- 0.0000.00%
FUFENG GROUP News
Fufeng Group (00546.HK): Performance is in line with expectations, high dividends drive value revaluation
Fufeng Group (0546.HK): Profit attributable to shareholders fell 24.10% year on year in 2023H1 and actively implemented the internationalization strategy
Fufeng Group (00546.HK): 1H23 performance is in line with expectations and awaits improvement in amino acid supply and demand
Fufeng Group (0546.HK): Profit attributable to shareholders increased by 201.5% year-on-year in 2022, benefiting from the boom in xanthan gum
Fufeng Group (0546.HK) handover coverage: Profit attributable to shareholders increased 201.5% year-on-year in 2022, benefiting from the high boom in xanthan gum
Fufeng Group (00546.HK): A sharp rise in volume and price, high growth in revenue and profit
Fufeng Group (00546.HK): Performance meets expectations, high dividends, shared growth
Fufeng Group (00546.HK): Steady revenue growth and sharp increase in profit
Fufeng Group (00546.HK): 1H22 performance exceeds expectations and plans to expand overseas production to enhance competitiveness
Fufeng Group (0546.HK): Shareholders should account for 2,026 million yuan of profit during the 2022 H1 period, an increase of 242.8% year-on-year, which is expected to benefit from the continuation of the high boom in xanthan gum
Fufeng Group (0546.HK): The year-on-year increase in net profit in 2022/H1 was more than 100% optimistic about the company's long-term performance growth
Fufeng Group (00546.HK): 1H21 performance is in line with expectations, waiting for demand to recover
Fufeng Group (00546.HK): Prices for various products such as monosodium glutamate and feed amino acids are rising, and the supply and demand pattern continues to improve
Fufeng Group (00546.HK): The results for the first half of the year are in line with expectations, and a moderate recovery in demand is expected to usher in a rebound in product prices
Fufeng Group (00546.HK): 2019 results are in line with expectations due to the impact of the epidemic, monosodium glutamate prices are under pressure in the short term
Fufeng Group (00546.HK): Monosodium glutamate stocks temporarily rise, prices are under short-term pressure, profits in the first half of the year increased 95% year-on-year
Fufeng Group (00546.HK): monosodium glutamate prices remain high and profit is expected to increase sharply in the first half compared with the same period last year.
Fufeng Group (00546.HK): MSG prices remain high; amino acid sector is expected to recover
Fufeng Group (00546.HK) in the report comments: cost pressure affects the first half of the performance; monosodium glutamate business is expected to improve in the second half of the year
Fufeng Group (00546.HK) Annual report comments: product prices and profit growth are under pressure to downgrade to neutral
Analysis
Price Target
No Data
